NM_004058.5:c.53G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004058.5(CAPS):​c.53G>A​(p.Arg18His) variant causes a missense change. The variant allele was found at a frequency of 0.0131 in 1,612,424 control chromosomes in the GnomAD database, including 191 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 14 hom., cov: 33)
Exomes 𝑓: 0.014 ( 177 hom. )

Consequence

CAPS
NM_004058.5 missense

Scores

3
4
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.85

Publications

5 publications found
Variant links:
Genes affected
CAPS (HGNC:1487): (calcyphosine) This gene encodes a calcium-binding protein, which may play a role in the regulation of ion transport. A similar protein was first described as a potentially important regulatory protein in the dog thyroid and was termed as R2D5 antigen in rabbit. Alternative splicing of this gene generates two transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009452552).
BP6
Variant 19-5914459-G-A is Benign according to our data. Variant chr19-5914459-G-A is described in ClinVar as [Benign]. Clinvar id is 781743.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.0136 (19907/1460126) while in subpopulation NFE AF = 0.016 (17785/1111432). AF 95% confidence interval is 0.0158. There are 177 homozygotes in GnomAdExome4. There are 9497 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAPSNM_004058.5 linkc.53G>A p.Arg18His missense_variant Exon 2 of 5 ENST00000588776.8 NP_004049.3 Q13938-4A0A384NYV7Q96ET4
CAPSNM_080590.4 linkc.53G>A p.Arg18His missense_variant Exon 2 of 5 NP_542157.3 Q13938

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAPSENST00000588776.8 linkc.53G>A p.Arg18His missense_variant Exon 2 of 5 1 NM_004058.5 ENSP00000465883.2 Q13938-4
ENSG00000267314ENST00000588891.1 linkn.*148G>A non_coding_transcript_exon_variant Exon 3 of 4 4 ENSP00000468419.1 K7ERU9
ENSG00000267314ENST00000588891.1 linkn.*148G>A 3_prime_UTR_variant Exon 3 of 4 4 ENSP00000468419.1 K7ERU9

Frequencies

GnomAD3 genomes
AF:
0.00840
AC:
1278
AN:
152180
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00316
Gnomad AMI
AF:
0.0636
Gnomad AMR
AF:
0.00478
Gnomad ASJ
AF:
0.00979
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00372
Gnomad FIN
AF:
0.00480
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0131
Gnomad OTH
AF:
0.00766
GnomAD2 exomes
AF:
0.00808
AC:
2020
AN:
250124
AF XY:
0.00812
show subpopulations
Gnomad AFR exome
AF:
0.00267
Gnomad AMR exome
AF:
0.00417
Gnomad ASJ exome
AF:
0.00878
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00630
Gnomad NFE exome
AF:
0.0127
Gnomad OTH exome
AF:
0.00671
GnomAD4 exome
AF:
0.0136
AC:
19907
AN:
1460126
Hom.:
177
Cov.:
33
AF XY:
0.0131
AC XY:
9497
AN XY:
726202
show subpopulations
African (AFR)
AF:
0.00248
AC:
83
AN:
33462
American (AMR)
AF:
0.00389
AC:
174
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00808
AC:
211
AN:
26126
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39680
South Asian (SAS)
AF:
0.00422
AC:
364
AN:
86228
European-Finnish (FIN)
AF:
0.00737
AC:
386
AN:
52384
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5762
European-Non Finnish (NFE)
AF:
0.0160
AC:
17785
AN:
1111432
Other (OTH)
AF:
0.0147
AC:
887
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1142
2285
3427
4570
5712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00838
AC:
1277
AN:
152298
Hom.:
14
Cov.:
33
AF XY:
0.00756
AC XY:
563
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00315
AC:
131
AN:
41546
American (AMR)
AF:
0.00477
AC:
73
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00979
AC:
34
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00373
AC:
18
AN:
4832
European-Finnish (FIN)
AF:
0.00480
AC:
51
AN:
10626
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0131
AC:
894
AN:
68014
Other (OTH)
AF:
0.00758
AC:
16
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
66
131
197
262
328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0112
Hom.:
41
Bravo
AF:
0.00802
TwinsUK
AF:
0.0162
AC:
60
ALSPAC
AF:
0.0161
AC:
62
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.0151
AC:
130
ExAC
AF:
0.00806
AC:
979
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0118
EpiControl
AF:
0.0110

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 26, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

CAPS-related disorder Benign:1
Aug 09, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.30
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.090
.;.;T
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Pathogenic
0.98
D;D;D
MetaRNN
Benign
0.0095
T;T;T
MetaSVM
Benign
-0.76
T
PhyloP100
4.9
PrimateAI
Uncertain
0.52
T
REVEL
Benign
0.22
Sift4G
Pathogenic
0.0010
D;D;D
Vest4
0.66
MVP
0.83
ClinPred
0.10
T
GERP RS
5.0
PromoterAI
-0.021
Neutral
Varity_R
0.32
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143117009; hg19: chr19-5914470; COSMIC: COSV99032936; COSMIC: COSV99032936; API